Stretching the structural envelope of isomeric imatinib analogs that reduce β-amyloid production by modulating both β- and γ-secretase cleavages of APP
W. J. Netzer, A. Sinha, M. Ghias, E. Chang, K. Gindinova, E. Mui, J.-S. Seo, S. Sinha
The paper investigates how structurally diverse imatinib analogs affect APP metabolism similarly, identifying potent isomers for further development.
bioRxiv · Jul 14, 2024Pharmacology & Toxicology